Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018

Stakeholders To Gather In London To Plan Biosimilar Market’s Future

17 April 2018

Increasing access to cancer medicines: what role do biosimilar medicines play?

9 April 2018

What Challenges Should Biosimilar Companies Expect In 2018?

10 January 2018

2018 Outlook: Biosimilar Trends To Watch

3 January 2018

Did The 2017 Biosimilar Industry Pave The Way For A Productive 2018?

28 December 2017